United States · FDA National Drug Code directory
Heparin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-519_3bbbe74a-1246-41a6-9fc3-ca0230529b40
- Product NDC
- 63323-519
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Heparin Sodium
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200724
- Source listing expiry
- 20261231
Source-listed ingredients
- HEPARIN SODIUM — 200 [USP'U]/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 12 BAG in 1 CASE (63323-519-10) / 1000 mL in 1 BAG (63323-519-01) · 63323-519-10
- 24 BAG in 1 CASE (63323-519-77) / 500 mL in 1 BAG (63323-519-02) · 63323-519-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →